Please login to the form below
lisdexamfetamine
This page shows the latest lisdexamfetamine news and features for those working in and with pharma, biotech and healthcare.
Shire claims FDA approval for slow-cooked ADHD drug
top ADHD seller Vyvanse (lisdexamfetamine dimesylate) - which pulled in $2bn in sales last year, a rise of 17% and added another $563m in the first quarter.
Latest news
-
Shire pitching at adult ADHD product launch in 2017
Breaking into the adult ADHD - as well as a sideways move into binge-eating disorder with paediatric ADHD therapy Vyvanse (lisdexamfetamine) - could eventually double sales of Shire's psychiatric portfolio by
-
Monica Seles to front Shire’s binge eating disorder campaign
Shire recently won the first approval in the US for a medicine to help people with binge eating disorder with FDA backing for Vyvanse (lisdexamfetamine dimesylate).
-
Shire gets FDA nod for first binge-eating treatment
Vyvanse (lisdexamfetamine dimesylate) has been used to treat attention-deficit hyperactivity disorder (ADHD) for several years and remains Shire's top-selling product; sales rose 19% to reach more than $1bn
-
AbbVie coaxes Shire into discussions with sweetened offer
Shire has a well-established franchise in attention-deficit hyperactivity disorder (ADHD) drugs, currently headed by Vyvanse (lisdexamfetamine dimesylate), but has latterly built up a portfolio of rare disease therapies such
-
Shire to file Vyvanse for binge-eating in Q3
The company revealed yesterday that sales of Vyvanse (lisdexamfetamine) for ADHD rose 29 per cent in the fourth quarter to $330m, more than a quarter of Shire's total revenues of
More from news
Approximately 3 fully matching, plus 22 partially matching documents found.
Featured jobs
-
Experienced Medical Writers
-
Competitive Salary and Benefits
- Account Manager- Healthcare Advertising
-
Negotiable
-
Medical (Scientific) Director
-
£120, 000 benefits
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Account Executive/ Senior Account Executive
-
competitive Salary Offfered
- Account Manager- Healthcare Advertising
-
Negotiable
-
Account Manager / Account Director
-
Competative
- Business Development Director – Health Education
-
excellent commission
-
Account Manager
-
Negotiable
-
Business Director
-
Competitive Salary Offered
-
Senior Account Manager
-
Competitive Salary Offered
- Senior Account Executive with progression to Account Manager, Me...
-
Excellent package
Subscribe to our email news alerts
- Fishawack acquires Blue Latitude Health
- FDA clears Sandoz and Pear’s Opioid Use Disorder app
- As May delays, industry warns again of ‘no-deal’ Brexit
- Clark Health Communications and Egg digital announce new collaboration
- Axovant drops last ‘legacy’ drug to focus on gene therapies
- Healthcare excellence celebrated at 2018 HSJ Awards
PMHub
Atlantis Healthcare
Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...
Latest intelligence
- Report: Achieving launch excellence in the challenging healthcare markets of today
- Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
- What is blockchain and why should i care - Richard Springham
- Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
- NHS medicines optimisation milestone
- Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...
Quick links
Infographics
